Treatment of inflammatory diseases using placental stem cells
First Claim
Patent Images
1. A method of treating an individual having inflammatory bowel disease, comprising administering to the individual a therapeutically effective amount of non-hematopoietic placental stem cells, wherein said placental stem cells are CD10+,CD34−
- , CD105+, CD200+, and CD117−
as detectable by flow cytometry, and wherein the therapeutically effective amount is an amount sufficient to cause a detectable improvement in one or more symptoms of said inflammatory bowel disease.
2 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.
-
Citations
18 Claims
-
1. A method of treating an individual having inflammatory bowel disease, comprising administering to the individual a therapeutically effective amount of non-hematopoietic placental stem cells, wherein said placental stem cells are CD10+,CD34−
- , CD105+, CD200+, and CD117−
as detectable by flow cytometry, and wherein the therapeutically effective amount is an amount sufficient to cause a detectable improvement in one or more symptoms of said inflammatory bowel disease. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
- , CD105+, CD200+, and CD117−
Specification